Literature DB >> 16297661

Have we cut ourselves too short in mapping CTL epitopes?

Scott R Burrows1, Jamie Rossjohn, James McCluskey.   

Abstract

MHC class I molecules generally present peptides of eight to ten amino acids; however, peptides of 11-14 residues can also elicit dominant cytotoxic T lymphocyte responses, sometimes at the expense of overlapping shorter peptides. Although long-bulged epitopes are considered to represent a barrier for T cell receptor recognition, recent structural data reveal how these super-bulged peptides are engaged while simultaneously maintaining MHC restriction. We propose that algorithms widely used to predict class I-binding peptides should now be broadened to include peptides of over ten residues in length.

Mesh:

Substances:

Year:  2005        PMID: 16297661     DOI: 10.1016/j.it.2005.11.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  54 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

2.  Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome.

Authors:  Anuska Llano; Christian Brander
Journal:  Cell Res       Date:  2012-07-10       Impact factor: 25.617

3.  The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.

Authors:  Christina Bade-Döding; Alex Theodossis; Stephanie Gras; Lars Kjer-Nielsen; Britta Eiz-Vesper; Axel Seltsam; Trevor Huyton; Jamie Rossjohn; James McCluskey; Rainer Blasczyk
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

4.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.

Authors:  Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

5.  Structure of HLA-A*1101 in complex with a hepatitis B peptide homologue.

Authors:  Thomas Blicher; Jette Sandholm Kastrup; Lars Østergaard Pedersen; Søren Buus; Michael Gajhede
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-04

6.  Comparison of performance in two diagnostic methods for tuberculosis infection.

Authors:  Kazue Higuchi; Yoshiko Kawabe; Satoshi Mitarai; Takashi Yoshiyama; Nobuyuki Harada; Toru Mori
Journal:  Med Microbiol Immunol       Date:  2008-11-26       Impact factor: 3.402

7.  Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.

Authors:  Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

8.  Naturally processed non-canonical HLA-A*02:01 presented peptides.

Authors:  Chopie Hassan; Eric Chabrol; Lorenz Jahn; Michel G D Kester; Arnoud H de Ru; Jan W Drijfhout; Jamie Rossjohn; J H Frederik Falkenburg; Mirjam H M Heemskerk; Stephanie Gras; Peter A van Veelen
Journal:  J Biol Chem       Date:  2014-12-12       Impact factor: 5.157

9.  Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.

Authors:  Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

10.  Computer aided selection of candidate vaccine antigens.

Authors:  Darren R Flower; Isabel K Macdonald; Kamna Ramakrishnan; Matthew N Davies; Irini A Doytchinova
Journal:  Immunome Res       Date:  2010-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.